These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 19699923)

  • 21. Pneumonectomy after chemotherapy: morbidity, mortality, and long-term outcome.
    Alifano M; Boudaya MS; Salvi M; Collet JY; Dinu C; Camilleri-Broët S; Régnard JF
    Ann Thorac Surg; 2008 Jun; 85(6):1866-72; discussion 1872-3. PubMed ID: 18498785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.
    Allen AM; Mentzer SJ; Yeap BY; Soto R; Baldini EH; Rabin MS; Sugarbaker DJ; Bueno R
    Cancer; 2008 Mar; 112(5):1106-13. PubMed ID: 18286507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
    Rojas AM; Lyn BE; Wilson EM; Williams FJ; Shah N; Dickson J; Saunders MI
    Cancer; 2006 Sep; 107(6):1321-30. PubMed ID: 16902985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does chemotherapy increase the risk of respiratory complications after pneumonectomy?
    Leo F; Solli P; Veronesi G; Radice D; Floridi A; Gasparri R; Petrella F; Borri A; Galetta D; Spaggiari L
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):519-23. PubMed ID: 16935104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative complications of pulmonary resection after platinum-based induction chemotherapy for primary lung cancer.
    Muraoka M; Oka T; Akamine S; Tagawa T; Nagayasu T; Tagawa Y; Ayabe H
    Surg Today; 2003; 33(1):1-6. PubMed ID: 12560899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung resection in patients with compromised pulmonary function.
    Cerfolio RJ; Allen MS; Trastek VF; Deschamps C; Scanlon PD; Pairolero PC
    Ann Thorac Surg; 1996 Aug; 62(2):348-51. PubMed ID: 8694589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis.
    Refai M; Brunelli A; Rocco G; Ferguson MK; Fortiparri SN; Salati M; La Rocca A; Kawamukai K
    Eur J Cardiothorac Surg; 2010 Mar; 37(3):535-9. PubMed ID: 19836257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of pneumonectomy after induction therapy for locally advanced non-small cell lung cancer.
    d'Amato TA; Ashrafi AS; Schuchert MJ; Alshehab DS; Seely AJ; Shamji FM; Maziak DE; Sundaresan SR; Ferson PF; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2009 Oct; 88(4):1079-85. PubMed ID: 19766784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
    J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.
    Bonomi P; Faber LP; Recine D; Lincoln S
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer.
    Subotic DR; Mandaric DV; Eminovic TM; Gajic MM; Mujovic NM; Atanasijadis ND; Dzeletovic PP; Andric LD; Bulajic BM; Dimitrijevic ID; Sobic DP
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1292-9. PubMed ID: 17976465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Video-assisted thoracic surgery pulmonary resection for lung cancer in patients with poor lung function.
    Garzon JC; Ng CS; Sihoe AD; Manlulu AV; Wong RH; Lee TW; Yim AP
    Ann Thorac Surg; 2006 Jun; 81(6):1996-2003. PubMed ID: 16731119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
    Huber RM; Flentje M; Schmidt M; Pöllinger B; Gosse H; Willner J; Ulm K;
    J Clin Oncol; 2006 Sep; 24(27):4397-404. PubMed ID: 16983107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions].
    Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ
    Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Segmental resection spares pulmonary function in patients with stage I lung cancer.
    Keenan RJ; Landreneau RJ; Maley RH; Singh D; Macherey R; Bartley S; Santucci T
    Ann Thorac Surg; 2004 Jul; 78(1):228-33; discussion 228-33. PubMed ID: 15223434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.